Latest News and Press Releases
Want to stay updated on the latest news?
-
AUSTIN, Texas, Aug. 17, 2021 (GLOBE NEWSWIRE) -- SecureLink, a leader in third-party security, ranked 2645 on Inc. Magazine’s 2021 list of the fastest-growing private companies in the United States....
-
PHILADELPHIA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations...
-
LEWES, Del., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Intel 471, the premier provider of cybercrime intelligence for leading intelligence, security, and fraud teams, today revealed that it has earned a...
-
SALT LAKE CITY, Aug. 05, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics for...
-
• Lumos Pharma strengthens leadership team with promotion of John McKew, PhD to President, and addition of David B. Karpf, MD as Chief Medical Officer and Mark Bach, MD, PhD to Advisory Board •...
-
Apeldoorn, Netherlands, Aug. 04, 2021 (GLOBE NEWSWIRE) -- As businesses look for ways to remain safely open, Biozek Medical announced the launch of their new COVID-19 Antigen Saliva Rapid test, a...
-
OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business
Excluding COVID-19 product revenues, revenues for the second quarter grew 122% YoY and 48% sequentially as the Company’s core business began to return to pre-pandemic revenue levelsCompany received...
-
AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced that...
-
Farmington, CT, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Specialist insurer Beazley has named Florian Beerli as the head of the newly named Specialty Risks & US Programs team. In addition to his new...
-
AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced that current...